ICDS Ltd
₹48.02
-0.98 (2.00%)
Fri, 06 Nov 2026, 09:58 pm
ICDS News
ICDS Ltd adopts FY26 financials at 55th AGM
ICDS Ltd shareholders adopted audited FY26 financial statements and approved related party transactions with Manipal Properties Ltd during the 55th AGM held via video conference.
24 Sept 2026
companies
ICDS Limited FY26 net profit falls 22%
ICDS Limited reported a 22% decline in consolidated net profit to ₹109.31 lakh for FY26. Revenue from operations fell to ₹239.21 lakh from ₹390.18 lakh in the previous year.
29 May 2026
companies
ICDS Ltd Board Meet on May 29
ICDS Ltd board meets on May 29, 2026 to consider Q4FY26 financial results. Trading window closed from April 01 to May 31, 2026.
20 May 2026
companies
ICDS Limited Approves Rs 5 Crore Inter-Corporate Loan
ICDS Limited's Board approved an inter-corporate loan of up to Rs 5 crore to Manipal Energy and Infratech Limited at 12% annual interest, repayable within 12 months from disbursement date.
30 Apr 2026
companies
ICDS Limited Approves Rs 5 Crore Inter-Corporate Loan
ICDS Limited's Board approved an inter-corporate loan of up to Rs 5 crore to Manipal Energy and Infratech Limited at 12% annual interest, repayable within 12 months from disbursement date.
30 Apr 2026
companies
Market Current News
CONTINENTAL CONTROLS LTD.
Continental Controls rights issue oversubscribed
Continental Controls Limited completed its rights issue of 1.96 crore shares at ₹10 each. The issue was oversubscribed 112.75% and shares list on BSE on November 5, 2026.
05 Nov 2026
ipo
Jivial Industries Limited
Jivial Industries changes IPO machinery vendors
Jivial Industries Ltd approved partial vendor changes for three machinery sets in its IPO project. Costs and timelines remain unchanged despite the switch.
05 Nov 2026
ipo
Antala IPO Day 6: Subscribed 6.43x
Antala Industries IPO sees strong QIB demand at 66.72x on final day. Total subscription reaches 6.43x as Retail and NII interest picks up.
05 Nov 2026
ipo
IGL Spirits lists on BSE and NSE post-demerger
IGL Spirits Limited listed on BSE and NSE on November 4, 2026. The demerged entity reported FY26 revenue of ₹2,801 crore and EBITDA of ₹492 crore.
04 Nov 2026
ipo
Ennature Bio Pharma lists on NSE, BSE
Ennature Bio Pharma Limited listed on NSE and BSE on November 4, 2026. The biopharma division reported ₹246 crore revenue in FY26, driven by branded nutraceuticals.
04 Nov 2026
ipo